Bone Health and Osteoporosis Prevention and Treatment
- PMID: 33017332
- DOI: 10.1097/GRF.0000000000000572
Bone Health and Osteoporosis Prevention and Treatment
Abstract
Postmenopausal osteoporosis is a common condition and is associated with increased risk of fracture, including hip and vertebral fractures that in turn can have devastating consequences on morbidity and mortality. In this article, we review the pathogenesis and diagnostic approach to postmenopausal osteoporosis. We review available nonpharmacologic and pharmacologic therapies and we discuss their clinical efficacy and complications, with a detailed discussion of atypical femur fractures and osteonecrosis of the jaw.
Similar articles
-
Clinical Practice. Postmenopausal Osteoporosis.N Engl J Med. 2016 Jan 21;374(3):254-62. doi: 10.1056/NEJMcp1513724. N Engl J Med. 2016. PMID: 26789873 Review.
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.Lancet Diabetes Endocrinol. 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. Epub 2019 Oct 31. Lancet Diabetes Endocrinol. 2019. PMID: 31676222 Clinical Trial.
-
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6. Menopause. 2010. PMID: 20061894
-
Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review.Ann Intern Med. 2019 Jul 2;171(1):37-50. doi: 10.7326/M19-0533. Epub 2019 Apr 23. Ann Intern Med. 2019. PMID: 31009947
-
Postmenopausal osteoporosis.Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):501-9. doi: 10.1097/01.med.0000436194.10599.94. Curr Opin Endocrinol Diabetes Obes. 2013. PMID: 24150190 Review.
Cited by
-
The importance of the UGT1A1 variants in the development of osteopenia and osteoporosis in postmenopausal women.Sci Rep. 2021 Aug 30;11(1):17385. doi: 10.1038/s41598-021-96429-x. Sci Rep. 2021. PMID: 34462452 Free PMC article.
-
Characteristics of the gut microbiota and serum metabolites in postmenopausal women with reduced bone mineral density.Front Cell Infect Microbiol. 2024 Jun 7;14:1367325. doi: 10.3389/fcimb.2024.1367325. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38912210 Free PMC article.
-
[Research progress of bioactive scaffolds in repair and regeneration of osteoporotic bone defects].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Jan 15;39(1):100-105. doi: 10.7507/1002-1892.202410018. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025. PMID: 39848724 Free PMC article. Review. Chinese.
-
Nobiletin ameliorates hormone-induced osteoblast apoptosis by modulating JAK2/STAT3 signaling.J Mol Histol. 2025 Apr 25;56(3):142. doi: 10.1007/s10735-025-10424-4. J Mol Histol. 2025. PMID: 40278936 Free PMC article.
-
The effects of alfacalcidol combined with calcitonin in the treatment of osteoporosis and its influence on levels of inflammation.Am J Transl Res. 2024 May 15;16(5):1690-1700. doi: 10.62347/ZMAL4724. eCollection 2024. Am J Transl Res. 2024. PMID: 38883381 Free PMC article.
References
-
- NIH Consensus Development Panel on Osteoporosis. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–795.
-
- Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29:2520–2526.
-
- Eastell R, Rosen CJ, Black DM, et al. Pharmacological management of osteoporosis in postmenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2019;104:1595–1622.
-
- Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008;23:205–214.
-
- Kurihara N, Chenu C, Miller M, et al. Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology. 1990;126:2733–2741.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical